Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Q32 Bio Inc.
Bear Case (25th pct.)
92.0% vs price
Base Case (Median)
107.6% vs price
Bull Case (75th pct.)
119.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $16.77 | 106.5% | High (40%) |
| Graham Number | $12.04 | 48.3% | Medium (40%) |
| EV/EBITDA | $16.95 | 108.7% | Medium (20%) |
| Earnings Power Value | $20.44 | 151.7% | Medium (50%) |
Based on 4 out of 7 methods, QTTB appears undervalued at the current price of $8.12. The base case fair value of $16.86 implies 107.6% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.